Log In
Print this Print this

Tabex, cytisine

  Manage Alerts
Collapse Summary General Information
Company Bulgarian Pharmaceutical Group Ltd.
DescriptionNicotinic acetylcholine receptor alpha(4)beta(2) partial agonist
Molecular Target Nicotinic acetylcholine receptor alpha(4)beta(2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsSmoking cessation
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today